BBA
EW icon

Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-116,500
Closed -$11M – 376
2023
Q2 		$11M Buy
+116,500
New +$10.1M 0.56% 69
2023
Q1 		– Sell
-236,000
Closed -$17.7M – 409
2022
Q4 		$17.7M Buy
+236,000
New +$18.2M 0.86% 42
2022
Q3 		– Sell
-81,700
Closed -$4.06M – 352
2022
Q2 		$4.06M Buy
+81,700
New +$8.46M 0.31% 73

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Baader Bank Aktiengesellschaft's EW Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 12% in Q2 2026, selling an estimated $765K and leaving 66,430 shares worth $6.01M. The position accounts for 0.45% of the portfolio, ranked #55.

Baader Bank Aktiengesellschaft first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.8M in Q1 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 66,430 shares of Edwards Lifesciences worth $6.01M as of Q2 2026.
  • Baader Bank Aktiengesellschaft sold 9,131 Edwards Lifesciences shares in Q2 2026, an estimated $765K.
  • Edwards Lifesciences made up 0.45% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #55 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • Baader Bank Aktiengesellschaft's Edwards Lifesciences position peaked at $13.8M in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.